glycopyrrolate 1.7 MG Disintegrating Oral Tablet [Dartisla]

RxNorm concept 2589281, branded drug (sbd). Prescribable name: Dartisla ODT 1.7 MG Disintegrating Oral Tablet.

RxCUI: 2589281
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2589281 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

glycopyrronium 1546438

Other names

Dartisla 1.7 MG Disintegrating Oral Tablet

Related concepts

glycopyrrolate 1.7 MG (SCDC, consists of)
glycopyrrolate 1.7 MG [Dartisla] (SBDC, consists of)
Disintegrating Oral Tablet (DF, has dose form)
Dartisla (BN, has ingredient)
glycopyrrolate 1.7 MG Disintegrating Oral Tablet (SCD, tradename of)

Linked data

NDCs

82111051801

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 2589281 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2589281 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2589281. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.